303A COLLEGE ROAD EAST, PRINCETON, NJ
Market cap: $37.2M (2/11/2026)
Price: $0.68
RdNCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate Cancer
PDS Biotech Gains New U.S. Patent for PDS0101, Extending Market Protection
Announces FDA Alignment on Use of Progression Free Survival (PFS) as Primary Endpoint
Announces New Composition of Matter Patent for PDS0101 in Japan
PDS Biotech Schedules Type C Meeting with FDA for Phase 3 Trial Amendment
Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
Announces up to $11.1 Million Registered Direct Offering
Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Correspondence
Submission Upload